US Patent Issued to THE UNIVERSITY OF BRITISH COLUMBIA on Feb. 17 for "Combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation" (Canadian Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,459, issued on Feb. 17, was assigned to THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver, Canada).

"Combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation" was invented by Aziz Ghahary (Vancouver, Canada), Reza B. Jalili (Vancouver, Canada), Ruhangiz T. Kilani (Vancouver, Canada) and Yunyuan Li (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides combinations of kynurenine and antigen presenting cells (APC) for modulating immune tolerance, wherein the combinations may be used to modulate an autoimmune response, which may be of use in the treatment ...